FDA Authorizes Novavax’s Updated COVID-19 Vaccine Targeting the XBB.1.5 Strain
![Novavax Vaccine Expanded to Target XBB.1.5 Variant](https://healthwire.co/wp-content/uploads/2023/09/covid19-1.jpg)
New Delhi, September 2: The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Novavax’s updated COVID-19 vaccine. Specifically targeting the XBB.1.5 variant, which was the…
Share